Close Menu

NEW YORK (GenomeWeb) – Elucidata, a developer of analytics software to support drug discovery, has signed a four-year contract with startup biotech firm Auron Therapeutics to provide data analytics for differentiation-based cancer therapies. Financial terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.